DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
TENOXICAM
4
Small molecule
Approved
Unknown
Unknown
Pain; Rheumatic Diseases
Unknown
TENOXICAM
×
Maximum Phase:
4
First Approval:
None
UNII:
Z1R9N0A399
Molecule Type:
Small molecule
Molecular Formula:
C13H11N3O4S2
Molecular Weight:
337.38
AlogP:
1.64
PSA:
99.6
HBD:
2.0
HBA:
#RotB:
2.0
Source:
PENTETATE CALCIUM TRISODIUM YB-169
4
Small molecule
Approved
OTHER
INJECTION
Unknown
Unknown
PENTETATE CALCIUM TRISODIUM YB-169
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CARBETOCIN
4
Protein
Unknown
Unknown
Unknown
Postpartum Hemorrhage; Prader-Willi Syndrome
Oxytocin receptor agonist
CARBETOCIN
×
Maximum Phase:
4
First Approval:
None
UNII:
88TWF8015Y
Molecule Type:
Protein
Molecular Formula:
C45H69N11O12S
Molecular Weight:
988.18
AlogP:
-2.5
PSA:
362.51
HBD:
10.0
HBA:
#RotB:
18.0
Source:
ETHYNODIOL DIACETATE; MESTRANOL
4
Combination
Approved
OTHER
ORAL-20; ORAL-21; ORAL-28
Unknown
Unknown
ETHYNODIOL DIACETATE; MESTRANOL
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DEXTROMETHORPHAN HYDROBROMIDE;QUINIDINE SULFATE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
DEXTROMETHORPHAN HYDROBROMIDE;QUINIDINE SULFATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MEPAZINE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
MEPAZINE
×
Maximum Phase:
4
First Approval:
None
UNII:
PH34873A38
Molecule Type:
Small molecule
Molecular Formula:
C19H22N2S
Molecular Weight:
310.47
AlogP:
4.63
PSA:
6.48
HBD:
0.0
HBA:
#RotB:
2.0
Source:
DIMETHINDENE
4
Small molecule
Unknown
Unknown
Unknown
Hypersensitivity; Pruritus
Histamine H1 receptor antagonist
DIMETHINDENE
×
Maximum Phase:
4
First Approval:
None
UNII:
661FH77Z3P
Molecule Type:
Small molecule
Molecular Formula:
C20H24N2
Molecular Weight:
292.43
AlogP:
4.15
PSA:
16.13
HBD:
0.0
HBA:
#RotB:
5.0
Source:
ERYTHROMYCIN ESTOLATE; SULFISOXAZOLE ACETYL
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
ERYTHROMYCIN ESTOLATE; SULFISOXAZOLE ACETYL
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DEXTRAN 70
4
Oligosaccharide
Approved
Unknown
Unknown
Diabetic Foot; Shock; Wounds and Injuries
Unknown
DEXTRAN 70
×
Maximum Phase:
4
First Approval:
None
UNII:
7SA290YK68
Molecule Type:
Oligosaccharide
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LYSINE
4
Small molecule
Approved
Unknown
Unknown
Diabetes Mellitus, Type 2; Prediabetic State; Myocardial Infarction
Radioprotective agent
LYSINE
×
Maximum Phase:
4
First Approval:
None
UNII:
K3Z4F929H6
Molecule Type:
Small molecule
Molecular Formula:
C6H14N2O2
Molecular Weight:
146.19
AlogP:
-0.47
PSA:
89.34
HBD:
3.0
HBA:
#RotB:
5.0
Source:
GLIMEPIRIDE; ROSIGLITAZONE MALEATE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
GLIMEPIRIDE; ROSIGLITAZONE MALEATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SIMVASTATIN; SITAGLIPTIN PHOSPHATE
4
Combination
Approved
DIABETES DRUGS & ENDOCRINOLOGY; OTHER
ORAL
Unknown
Unknown
SIMVASTATIN; SITAGLIPTIN PHOSPHATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ACETAMINOPHEN; DEXBROMPHENIRAMINE MALEATE; PSEUDOEPHEDRINE SULFATE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
ACETAMINOPHEN; DEXBROMPHENIRAMINE MALEATE; PSEUDOEPHEDRINE SULFATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PROPATYL NITRATE
4
Small molecule
Approved
Unknown
Unknown
Cardiovascular Diseases
Unknown
PROPATYL NITRATE
×
Maximum Phase:
4
First Approval:
None
UNII:
AJT2YN495R
Molecule Type:
Small molecule
Molecular Formula:
C6H11N3O9
Molecular Weight:
269.17
AlogP:
0.01
PSA:
157.11
HBD:
0.0
HBA:
#RotB:
10.0
Source:
HYDRARGAPHEN
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
HYDRARGAPHEN
×
Maximum Phase:
4
First Approval:
None
UNII:
DL2D409P9O
Molecule Type:
Small molecule
Molecular Formula:
C33H24Hg2O6S2
Molecular Weight:
981.86
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
PHENETHICILLIN
4
Small molecule
Approved
Unknown
Unknown
Bacterial Infections
Bacterial penicillin-binding protein inhibitor
PHENETHICILLIN
×
Maximum Phase:
4
First Approval:
None
UNII:
EFA30X554H
Molecule Type:
Small molecule
Molecular Formula:
C17H20N2O5S
Molecular Weight:
364.42
AlogP:
1.09
PSA:
95.94
HBD:
2.0
HBA:
#RotB:
5.0
Source:
PERTUZUMAB;TRASTUZUMAB;HYALURONIDASE-ZZXF
4
Combination
Approved
Unknown
Unknown
Unknown
Unknown
PERTUZUMAB;TRASTUZUMAB;HYALURONIDASE-ZZXF
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MAGNESIUM PIDOLATE
4
Small molecule
Approved
Unknown
Unknown
Anemia, Sickle Cell; Hemoglobin SC Disease
Unknown
MAGNESIUM PIDOLATE
×
Maximum Phase:
4
First Approval:
None
UNII:
V5PC588N7G
Molecule Type:
Small molecule
Molecular Formula:
C10H12MgN2O6
Molecular Weight:
280.52
AlogP:
-0.65
PSA:
66.4
HBD:
2.0
HBA:
#RotB:
1.0
Source:
DEXTROSE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM ACETATE; SODIUM CHLORIDE
4
Combination
Approved
OTHER
INJECTION
Unknown
Unknown
DEXTROSE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM ACETATE; SODIUM CHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SODIUM FERRIC GLUCONATE
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
SODIUM FERRIC GLUCONATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AMINO ACIDS; MAGNESIUM ACETATE; PHOSPHORIC ACID; POTASSIUM ACETATE; POTASSIUM CHLORIDE; SODIUM ACETATE
4
Combination
Approved
OTHER
INJECTION
Unknown
Unknown
AMINO ACIDS; MAGNESIUM ACETATE; PHOSPHORIC ACID; POTASSIUM ACETATE; POTASSIUM CHLORIDE; SODIUM ACETATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LEDIPASVIR; SOFOSBUVIR
4
Combination
Approved
UROLOGY AND KIDNEY
ORAL
Unknown
Unknown
LEDIPASVIR; SOFOSBUVIR
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
VITAMIN A
4
Small molecule
Approved
OTHER
ORAL
Unknown
Unknown
VITAMIN A
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ATROPINE SULFATE; DIFENOXIN HYDROCHLORIDE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
ATROPINE SULFATE; DIFENOXIN HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AMINO ACIDS; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM CHLORIDE
4
Combination
Approved
OTHER
INJECTION
Unknown
Unknown
AMINO ACIDS; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM CHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ASCORBIC ACID; BIOTIN; CYANOCOBALAMIN; ERGOCALCIFEROL; FOLIC ACID; NIACINAMIDE; PANTOTHENIC ACID; PHYTONADIONE; PYRIDOXINE; RIBOFLAVIN; THIAMINE; VITAMIN A PALMITATE; VITAMIN E
4
Combination
Approved
OTHER
INJECTION
Unknown
Unknown
ASCORBIC ACID; BIOTIN; CYANOCOBALAMIN; ERGOCALCIFEROL; FOLIC ACID; NIACINAMIDE; PANTOTHENIC ACID; PHYTONADIONE; PYRIDOXINE; RIBOFLAVIN; THIAMINE; VITAMIN A PALMITATE; VITAMIN E
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ESTRADIOL HEMIHYDRATE
4
Small molecule
Approved
OTHER
TOPICAL
Unknown
Unknown
ESTRADIOL HEMIHYDRATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AMMONIA N-13
4
Small molecule
Approved
OTHER
INTRAVENOUS
Unknown
Unknown
AMMONIA N-13
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
HEME IRON POLYPEPTIDE
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
HEME IRON POLYPEPTIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
NAPHAZOLINE HYDROCHLORIDE; PHENIRAMINE MALEATE
4
Combination
Approved
OTHER
OPHTHALMIC
Unknown
Unknown
NAPHAZOLINE HYDROCHLORIDE; PHENIRAMINE MALEATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SILICATE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
SILICATE
×
Maximum Phase:
4
First Approval:
None
UNII:
4OI8D3YOH1
Molecule Type:
Small molecule
Molecular Formula:
H2O3Si
Molecular Weight:
78.1
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
SODIUM ALGINATE
4
Unknown
Approved
Unknown
Unknown
Gastroesophageal Reflux; Laryngopharyngeal Reflux
Unknown
SODIUM ALGINATE
×
Maximum Phase:
4
First Approval:
None
UNII:
C269C4G2ZQ
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
HYDROCODONE BITARTRATE; IBUPROFEN
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
HYDROCODONE BITARTRATE; IBUPROFEN
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CYANOCOBALAMIN CO 57
4
Small molecule
Approved
Unknown
Unknown
Unknown
Diagnostic agent
CYANOCOBALAMIN CO 57
×
Maximum Phase:
4
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C63H89CoN14O14P
Molecular Weight:
1354.4
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
EPINEPHRINE; ETIDOCAINE HYDROCHLORIDE
4
Combination
Approved
OTHER
INJECTION
Unknown
Unknown
EPINEPHRINE; ETIDOCAINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
1
2
…
259
260
261
262
263
264
265
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA